Gyms, wearables, activewear, and healthtech are all benefiting as GLP-1s serve as an entry point for a new wave of wellness consumers
Cardiovascular disease and risk management: Standards of Medical Care in Diabetes-2022
Reta Fuels Investor Optimism Much of the recent excitement centers on retatrutide, or "Reta," Eli Lilly's experimental next-generation obesity treatment
The susceptibility of isolates to meropenem increased when the concentration of GSH was either 1.5 mg/mL or 3 mg/mL, with the maximum improvement reaching up to a 4-fold increase in susceptibility (Figure 1C)
Actual product packaging and materials may contain more and/or different information than that shown on our website
The Precision Peptide Genetic Test reveals predispositions in GLP-1 receptor, GIPR, and metabolic pathwaysnot exact medication response